The Bishop of St Albans received the following written answer on 25th October 2023:
The Lord Bishop of St Albans asked His Majesty’s Government what discussions they have had with Servier to expand access to vorasidenib for patients that might benefit by including it in the early access to medicines scheme, or by any other means.
Lord Markham (Con, DHSC): The Department has had no specific discussions with Servier regarding vorasidenib, and neither has the Medicines and Healthcare Products Regulatory Agency (MHRA). The MHRA has not issued a scientific opinion for Vorasidenib under the early access to medicines scheme but should an application for this be received, the MHRA will consider this accordingly.
The Church of England in Parliament 
You must be logged in to post a comment.